Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Thursday, January 19 2017 5:22am ET - U.S. Markets open in 4 hours and 8 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Drug Manufacturers - Other
Composite Value: 1024.3
Today's Change: +0.36%
S&P 500: +0.18%
chart for
[Drug Manufacturers - Other (^YHOh784)]
Drug Manufacturers - Other News
FDA issues draft guidance to better medical product labeling
2 hours, 36 minutes ago (Reuters)
The U.S. health regulator issued draft guidance, recommending ways to communicate promotional materials and additional information that is not on the label of medical products. The U.S. Food and Drug Administration typically determines what information goes on the labels of medical drugs and devices, after evaluating whether the product is safe and effective for the proposed indication. If a firm communicates information, including on promotional material, that has not been evaluated by the regulator, but appears to be FDA-ratified, then it could lead to misbranding, and could subject firms to enforcement action if the representations or suggestions are considered false or misleading.
FDA proposes off-label communication norms for medical products - (Reuters)
Teva's Pain Drug Gets Approved By The FDA - (at Investopedia)
More News on Drug Manufacturers - Other: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
Novo Nordisk A/S Common Stock [NVO] -0.44% $91.5 B
Teva Pharmaceutical Industries [TEVA] +1.04% $34.3 B
Dr. Reddy's Laboratories Ltd Co [RDY] +0.09% $7.2 B
United Therapeutics Corporation [UTHR] +3.29% $6.3 B
Taro Pharmaceutical Industries [TARO] -0.44% $4.3 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Recent Events
Date Co Event
01/09/17 TEVA Teva Pharmaceutical Industries downgraded by Wells Fargo
01/06/17 TEVA Teva Pharmaceutical Industries downgraded by Maxim Group
01/05/17 ENDP Endo International plc - Ordina downgraded by Citigroup
More Recent Events...
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:150B
Price / Earnings:27.9
Price / Book:65.9
Net Profit Margin (mrq):18.5%
Price To Free Cash Flow (mrq):-92.0
Return on Equity:20.6%
Total Debt / Equity:45.7
Dividend Yield:0.0%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
DEPO
PCYC
TPPH
Unusually Active Boards
Board Variance
PCYC
ADLR
ARQL

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?